Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10447)
All Articles published online
|
Publishing Process of This Article
|
Feb 7, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pang Q, Zhang JY, Song SD, Qu K, Xu XS, Liu SS, Liu C. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol 2015; 21(5): 1650-1662 [PMID: 25663786 DOI: 10.3748/wjg.v21.i5.1650] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i5/1650.htm |
| Number | Citing Articles |
| 1 |
Florine Seidel, Robert Kleemann, Wim van Duyvenvoorde, Nikki van Trigt, Nanda Keijzer, Sandra van der Kooij, Cees van Kooten, Lars Verschuren, Aswin Menke, Amanda J. Kiliaan, Johnathan Winter, Timothy R. Hughes, B. Paul Morgan, Frank Baas, Kees Fluiter, Martine C. Morrison. Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences 2022; 23(18): 10736 doi: 10.3390/ijms231810736
|
| 2 |
Dan Eisenberg, Katherine D. Arnow, Nicolas B. Barreto, Kristen Davis, Sherri L. LaVela, Susan M. Frayne, Andrea L. Nevedal, Justina Wu, Alex H. S. Harris. Interaction between increasing body mass index and spinal cord injury to the probability of developing a diagnosis of nonalcoholic fatty liver disease. Obesity Science & Practice 2023; 9(3): 253 doi: 10.1002/osp4.643
|
| 3 |
Shari S. Bassuk, JoAnn E. Manson. International Encyclopedia of Public Health. 2017; : 244 doi: 10.1016/B978-0-323-99967-0.00362-8
|
| 4 |
Eun-Hee Nah, Yong Jun Choi, Seon Cho, Hyeran Park, Suyoung Kim, Eunjoo Kwon, Han-Ik Cho, Jee-Fu Huang. Changes in nonalcoholic fatty liver disease and M2BPGi due to lifestyle intervention in primary healthcare. PLOS ONE 2024; 19(2): e0298151 doi: 10.1371/journal.pone.0298151
|
| 5 |
Abbas Ali Sangouni, Mohammad Reza Mohammad Hosseini Azar, Mohammad Alizadeh. Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial. Complementary Therapies in Medicine 2020; 51: 102428 doi: 10.1016/j.ctim.2020.102428
|
| 6 |
Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel. Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review. Cancers 2024; 16(6): 1214 doi: 10.3390/cancers16061214
|
| 7 |
Abdullatif Suliman Alsayegh, Mohammed Abdullah Alduaybi, Hamoud Ghayyadh Alanizi, Nada Abdulrahman Amer Alajmi, Shahad Mohammed Bin Saeed, Meshal Ibrahim Zaid Al Owias, Adel Awad Al Rashedi, Asma Saad Alqahtani, Bader Sayah Alanezi. Fatty liver disease: An updated overview of risk factors. International journal of health sciences 2023; 7(S1): 3698 doi: 10.53730/ijhs.v7nS1.15308
|
| 8 |
Anna Andreasson, Axel C. Carlsson, Kristina Önnerhag, Hannes Hagström. Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population-based Cohort Study. Clinical Gastroenterology and Hepatology 2017; 15(8): 1294 doi: 10.1016/j.cgh.2017.02.040
|
| 9 |
Assim A. Alfadda, Suphia M. Sherbeeni, Adel N. Alqutub, Abdullah S. Aldosary, Nasser M. Aldaghri, Simon D. Taylor-Robinson, Saleh A. Alqahtani, Rukhsana Gul, Abdulrahman M. Almaghamsi. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes. Saudi Journal of Gastroenterology 2022; 28(6): 426 doi: 10.4103/sjg.sjg_73_22
|
| 10 |
Kyung Eun Yun, Ga Eun Nam, Jisun Lim, Hye Soon Park, Yoosoo Chang, Hyun-Suk Jung, Chan-Won Kim, Byung-Joon Ko, Eun Chul Chung, Hocheol Shin, Seungho Ryu, Giovanni Targher. Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study. PLOS ONE 2016; 11(7): e0158710 doi: 10.1371/journal.pone.0158710
|
| 11 |
Jun-Hyuk Lee, Soyoung Jeon, Hye Sun Lee, Yu-Jin Kwon. Cutoff Points of Waist Circumference for Predicting Incident Non-Alcoholic Fatty Liver Disease in Middle-Aged and Older Korean Adults. Nutrients 2022; 14(14): 2994 doi: 10.3390/nu14142994
|
| 12 |
Samantha Maurotti, Roberta Pujia, Elisa Mazza, Maria Francesca Pileggi, Franco Arturi, Maria Grazia Tarsitano, Tiziana Montalcini, Arturo Pujia, Yvelise Ferro. Low Relative Handgrip Strength Is Associated with a High Risk of Non-Alcoholic Fatty Liver Disease in Italian Adults: A Retrospective Cohort Study. Applied Sciences 2023; 13(22): 12489 doi: 10.3390/app132212489
|
| 13 |
Ammar Salehi-sahlabadi, Samaneh Sadat, Sara Beigrezaei, Makan Pourmasomi, Awat Feizi, Reza Ghiasvand, Amir Hadi, Cain C. T. Clark, Maryam Miraghajani. Dietary patterns and risk of non-alcoholic fatty liver disease. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01612-z
|
| 14 |
Eunji Ko, Eileen L. Yoon, Dae Won Jun. Risk factors in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 2023; 29(Suppl): S79 doi: 10.3350/cmh.2022.0398
|
| 15 |
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Sakura Iida, Hisayuki Katsuyama. Metabolic-Dysfunction-Associated Steatotic Liver Disease—Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments. International Journal of Molecular Sciences 2023; 24(20): 15473 doi: 10.3390/ijms242015473
|
| 16 |
Luiz F. Viola, Cynthia M. Valerio, João M. Araujo-Neto, Fabio F. Santos, Felipe Matsuura, Rodrigo O. Moreira, Amélio F. Godoy-Matos. Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy women. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01156-0
|
| 17 |
Soo-Hyun Lee, Moon-Jong Kim, Young-Sang Kim, Hyejin Chun, Bo Youn Won, Joo-Ho Lee, Kunhee Han, Kyu-Sung Rim, Kyung-Chae Park. Low hair copper concentration is related to a high risk of nonalcoholic fatty liver disease in adults. Journal of Trace Elements in Medicine and Biology 2018; 50: 28 doi: 10.1016/j.jtemb.2018.06.001
|
| 18 |
Fredrik Åberg, Martti Färkkilä, Ville Männistö. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies. Alcoholism: Clinical and Experimental Research 2020; 44(2): 384 doi: 10.1111/acer.14271
|
| 19 |
Qing Pang, Kai Qu, Chang Liu. Central Obesity Early in Adulthood May Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology 2015; 149(6): 1642 doi: 10.1053/j.gastro.2015.05.064
|
| 20 |
Alireza Ghaemi, Narjes Hosseini, Saeed Osati, Mohammad mehdi Naghizadeh, Azizallah dehghan, Elham Ehrampoush, Behnam Honarvar, Reza Homayounfar. Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-23192-x
|
| 21 |
Ken Liu, Geoffrey W. McCaughan. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 3 doi: 10.1007/978-981-10-8684-7_2
|
| 22 |
Robinson Ramírez-Vélez, Mikel Izquierdo, Jorge Enrique Correa-Bautista, María Correa-Rodríguez, Jacqueline Schmidt-RioValle, Emilio González-Jiménez, Katherine González-Jiménez. Liver Fat Content and Body Fat Distribution in Youths with Excess Adiposity. Journal of Clinical Medicine 2018; 7(12): 528 doi: 10.3390/jcm7120528
|
| 23 |
Ye Zhang, Jiaojiao Huang, Sanshan Xia, Yan Yang, Kun Dong. Gender Difference in Liver Enzymes in Newly Defined Subgroups of Diabetes Revealed by a Data-Driven Cluster Analysis. Experimental and Clinical Endocrinology & Diabetes 2022; 130(11): 758 doi: 10.1055/a-1799-8173
|
| 24 |
Yuting Gao, Tianyi Zhao, Shuoning Song, Yanbei Duo, Junxiang Gao, Tao Yuan, Weigang Zhao. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis. Diabetes Research and Clinical Practice 2023; 200: 110699 doi: 10.1016/j.diabres.2023.110699
|
| 25 |
Daljeet Chahal, Divya Sharma, Sareh Keshavarzi, Fakhar Ali Qazi Arisar, Keyur Patel, Wei Xu, Mamatha Bhat. Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank. Hepatology International 2022; 16(2): 325 doi: 10.1007/s12072-022-10304-z
|
| 26 |
Shuang Zhe Lin, Yuan Wen Chen, Jian Gao Fan. Non‐alcoholic fatty liver disease to metabolic dysfunction‐associated fatty liver disease: Conceptual changes for clinicians, researchers and patients. Journal of Digestive Diseases 2020; 21(11): 604 doi: 10.1111/1751-2980.12944
|
| 27 |
Louise Johanna Maria Alferink, Katerina Trajanoska, Nicole Stephanie Erler, Josje Dorothea Schoufour, Robert Jacobus de Knegt, M. Arfan Ikram, Harry Leonardus Antonius Janssen, Oscar H. Franco, Herold J. Metselaar, Fernando Rivadeneira, Sarwa Darwish Murad. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution. Journal of Bone and Mineral Research 2019; 34(7): 1254 doi: 10.1002/jbmr.3713
|
| 28 |
Francesco De Chiara, Ainhoa Ferret-Miñana, Javier Ramón-Azcón. The Synergy between Organ-on-a-Chip and Artificial Intelligence for the Study of NAFLD: From Basic Science to Clinical Research. Biomedicines 2021; 9(3): 248 doi: 10.3390/biomedicines9030248
|
| 29 |
Andrew D. Schreiner, Jingwen Zhang, William P. Moran, David G. Koch, Justin Marsden, Chloe Bays, Patrick D. Mauldin, Mulugeta Gebregziabher. Objective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Endocrine Practice 2024; 30(11): 1015 doi: 10.1016/j.eprac.2024.08.002
|
| 30 |
|
| 31 |
Josilda Ferreira CRUZ, Yasmim Anayr Costa FERRARI, Carla Perez MACHADO, Nathalia Nascimento SANTANA, Allan Victor Hora MOTA, Sonia Oliveira LIMA. SARCOPENIA AND SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE. Arquivos de Gastroenterologia 2019; 56(4): 357 doi: 10.1590/s0004-2803.201900000-66
|
| 32 |
M. Serdarova, R. Dimova, N. Chakarova, G. Grozeva, A. Todorova, P. Tsarkova, C. Marinova, D. Popov, L. Mateva, T. Tankova. Metabolic determinants of NAFLD in adults with type 1 diabetes. Diabetes Research and Clinical Practice 2022; 186: 109819 doi: 10.1016/j.diabres.2022.109819
|
| 33 |
Seyed Ahmad Hosseini, Ali Akbar Shayesteh, Seyed Jalal Hashemi, Zahra Rahimi, Nader Saki, Hossein Bavi Behbahani, Bahman Cheraghian, Meysam Alipour. The association between healthy eating index-2015 with anthropometric, cardiometabolic and hepatic indices among patients with non-alcoholic fatty liver disease. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03222-x
|
| 34 |
Dongna Zhao, Haozhe Cui, Zhiqiang Shao, Liying Cao. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. Annals of Hepatology 2023; 28(4): 100726 doi: 10.1016/j.aohep.2022.100726
|
| 35 |
Inês Rego de Figueiredo, Miguel Carvalho Vasques, Nelson Cunha, Diana Martins, José Silva-Nunes. Quality of Life in Obese Patients from a Multidisciplinary Bariatric Consultation: A Cross-Sectional Study Comparing to a Non-Bariatric Population and to the General Population. International Journal of Environmental Research and Public Health 2022; 19(19): 12029 doi: 10.3390/ijerph191912029
|
| 36 |
James L. Dorling, Eric Ravussin, Leanne M. Redman, Manju Bhapkar, Kim M. Huffman, Susan B. Racette, Sai K. Das, John W. Apolzan, William E. Kraus, Christoph Höchsmann, Corby K. Martin. Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. European Journal of Nutrition 2021; 60(3): 1633 doi: 10.1007/s00394-020-02361-7
|
| 37 |
Maobin Kuang, Jiajun Qiu, Dongdong Li, Chong Hu, Shuhua Zhang, Guotai Sheng, Yang Zou. The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1281524
|
| 38 |
Kazuhiro Kashiwagi, Michiyo Takayama, Kayoko Fukuhara, Ryoko Shimizu-Hirota, Po-Sung Chu, Nobuhiro Nakamoto, Nagamu Inoue, Yasushi Iwao, Takanori Kanai. A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity. Clinical Nutrition ESPEN 2020; 38: 86 doi: 10.1016/j.clnesp.2020.05.025
|
| 39 |
Edwin C. Chin, Chit K. Leung, Danny J. Yu, Angus P. Yu, Joshua K. Bernal, Christopher W. Lai, Derwin K.C. Chan, Heidi H. Ngai, Patrick S.H. Yung, Chi H. Lee, Daniel Y. Fong, Shelley E. Keating, Jeff S. Coombes, Parco M. Siu. Effects of one-year once-weekly high-intensity interval training on body adiposity and liver fat in adults with central obesity: Study protocol for a randomized controlled trial. Journal of Exercise Science & Fitness 2022; 20(2): 161 doi: 10.1016/j.jesf.2022.03.003
|
| 40 |
Mark L. Dreher. Dietary Patterns and Whole Plant Foods in Aging and Disease. 2018; : 291 doi: 10.1007/978-3-319-59180-3_10
|
| 41 |
Ahmed Nasser, Victoria Smith, Niamh Campbell, Michael Devin Rivers-Bowerman, Ashley Elispath Stueck, Andreu Francesc Costa, Riley Arseneau, Lauren Westhaver, Boris Luis Gala-Lopez. Is hepatocellular carcinoma viability important when using intraoperative blood salvage during liver transplantation?. International Journal of Gastrointestinal Intervention 2023; 12(3): 145 doi: 10.18528/ijgii230020
|
| 42 |
Lukas Hartl, Joshua Elias, Gerhard Prager, Thomas Reiberger, Lukas W Unger. Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. World Journal of Gastroenterology 2021; 27(19): 2281-2298 doi: 10.3748/wjg.v27.i19.2281
|
| 43 |
Sophie E. Kastberg, Helene S. Lund, Emanuella De Lucia‐Rolfe, Lydia U. Kaduka, Michael K. Boit, Eva Corpeleijn, Henrik Friis, Sophie Bernard, Martine Paquette, Alexis Baass, Jon J. Rasmussen, Dirk L. Christensen. Hepatic steatosis is associated with anthropometry, cardio‐metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans. Tropical Medicine & International Health 2022; 27(1): 49 doi: 10.1111/tmi.13696
|
| 44 |
Yang Xia, Qijun Wu, Huixu Dai, Jiale Lv, Yashu Liu, Hui Sun, Yuting Jiang, Qing Chang, Kaijun Niu, Yuhong Zhao. Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.642509
|
| 45 |
Maobin Kuang, Song Lu, Qiyang Xie, Nan Peng, Shiming He, Changhui Yu, Jiajun Qiu, Guotai Sheng, Yang Zou. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02393-9
|
| 46 |
Kajal Claypool, Michelle T. Long, Chirag J. Patel. Waist Circumference and Insulin Resistance Are the Most Predictive Metabolic Factors for Steatosis and Fibrosis. Clinical Gastroenterology and Hepatology 2023; 21(7): 1950 doi: 10.1016/j.cgh.2022.05.021
|
| 47 |
Xingqi Cao, Yeqing Gu, Shanshan Bian, Qing Zhang, Ge Meng, Li Liu, Hongmei Wu, Shunming Zhang, Yawen Wang, Tingjing Zhang, Xuena Wang, Shaomei Sun, Xing Wang, Qiyu Jia, Kun Song, Kaijun Niu. Association between eating speed and newly diagnosed nonalcoholic fatty liver disease among the general population. Nutrition Research 2020; 80: 78 doi: 10.1016/j.nutres.2020.06.012
|
| 48 |
Amr Hassan, Patrícia Rijo, Tamer M. M. Abuamara, Lashin Saad Ali Lashin, Sherif A. Kamar, Gabrielle Bangay, Majid Mohammed Al-Sawahli, Marina K. Fouad, Mohammad A. Zoair, Tamer I. Abdalrhman, Dalia Elebeedy, Ibrahim A. Ibrahim, Aly F. Mohamed, Ahmed I. Abd El Maksoud. Synergistic Differential DNA Demethylation Activity of Danshensu (Salvia miltiorrhiza) Associated with Different Probiotics in Nonalcoholic Fatty Liver Disease. Biomedicines 2024; 12(2): 279 doi: 10.3390/biomedicines12020279
|
| 49 |
Mohammad E. Khamseh, Mojtaba Malek, Rowshanak Abbasi, Hoda Taheri, Maryam Lahouti, Fariba Alaei-Shahmiri. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity. Metabolic Syndrome and Related Disorders 2021; 19(3): 167 doi: 10.1089/met.2020.0109
|
| 50 |
Luis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, Francisco Idalsoaga, Jorge Arnold, Andrea Márquez-Lomas, Carolina A Ramírez, María Paz Medel, Francisca Viñuela, Lucas Lacalle, Juan Pablo Roblero, Catterina Ferreccio, Mariana Lazo, Mayur Brahmania, Ashwani K Singal, Melisa Dirchwolf, Nahum Méndez-Sánchez, Norberto Chavez-Tapia, Patricia Guerra, Juan Carlos Restrepo, Claudia P Oliveira, Julissa Lombardo, Abel Sánchez, Martín Elizondo, Martín Tagle, Martín Padilla, Marco Sánchez, Enrique Carrera, Marcos Girala, Omega Chery, Marlen Castellanos-Fernández, Francisco Barrera, Jeffrey V Lazarus, Patrick S Kamath, Ramon Bataller, Marco Arrese, Juan Pablo Arab. The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas. The Lancet Gastroenterology & Hepatology 2022; 7(6): 552 doi: 10.1016/S2468-1253(22)00008-5
|
| 51 |
Xieyi Pei, Qingqing Deng, Zhuo Liu, Xiang Yan, Weiping Sun. Machine Learning Algorithms for Predicting Fatty Liver Disease. Annals of Nutrition and Metabolism 2021; 77(1): 38 doi: 10.1159/000513654
|
| 52 |
Min Seo Kim, Inhyeok Lee, Pradeep Natarajan, Ron Do, Yeongkeun Kwon, Jae Il Shin, Marco Solmi, Jong Yeob Kim, Hong‐Hee Won, Sungsoo Park. Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta‐analysis. Obesity Reviews 2024; 25(12) doi: 10.1111/obr.13823
|
| 53 |
Petar Avramovski, Maja Avramovska, Zorica Nikleski, Biljana Ilkovska, Kosta Sotiroski, Emilija Sikole. The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease. Indian Journal of Gastroenterology 2020; 39(1): 50 doi: 10.1007/s12664-019-01009-7
|
| 54 |
Angeliki Meritsi, Emanuel Manesis, Panagiotis Koussis, Stamatia Rapti, Dimitra Latsou, Eustathios Tsitsopoulos, Hariklia Moshoyianni, Spilios Manolakopoulos, Dimitrios Pektasides, Anastasia Thanopoulou. PNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus. Metabolic Syndrome and Related Disorders 2022; 20(2): 124 doi: 10.1089/met.2021.0098
|
| 55 |
Khaoula Errafii, Olfa Khalifa, Neyla S. Al-Akl, Abdelilah Arredouani. Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism. Biomedicines 2022; 10(5): 1020 doi: 10.3390/biomedicines10051020
|
| 56 |
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Annals of Hepatology 2020; 19(4): 359 doi: 10.1016/j.aohep.2020.03.001
|
| 57 |
Hanying Liu, Xiao Li, Xiaodong Han, Yan Zhang, Yanting Gu, Lianjie Sun, Junfeng Han, Yinfang Tu, Yuqian Bao, Wenkun Bai, Haoyong Yu. Simple surrogate equations to predict controlled attenuation parameter values for screening non-alcoholic fatty liver disease in a Chinese population. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.894895
|
| 58 |
M.ª Teófila Vicente-Herrero, M.ª Victoria Ramírez-Iñiguez de la Torre, Ángel Arturo López González. Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia. Revista Clínica de Medicina de Familia 2022; : 93 doi: 10.55783/rcmf.150205
|
| 59 |
Iasmin dos Santos Barreto, Raquel Oliveira dos Santos, Raquel Rocha, Claudineia de Souza, Naiade Almeida, Luiza Valois Vieira, Rafael Leiróz, Manoel Sarno, Carla Daltro, Helma Pinchemel Cotrim. Muscle mass and cellular membrane integrity assessment in patients with nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 2021; 67(9): 1233 doi: 10.1590/1806-9282.20201016
|
| 60 |
Maobin Kuang, Guotai Sheng, Chong Hu, Song Lu, Nan Peng, Yang Zou. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01717-8
|
| 61 |
Phillip E. Melton, M. A. Burton, K. A. Lillycrop, K. M. Godfrey, S. Rauschert, D. Anderson, G. C. Burdge, T. A. Mori, L. J. Beilin, O. T. Ayonrinde, J. M. Craig, J. K. Olynyk, J. D. Holbrook, C. E. Pennell, W. H. Oddy, E. K. Moses, L. A. Adams, R. C. Huang. Differential DNA methylation of steatosis and non-alcoholic fatty liver disease in adolescence. Hepatology International 2023; 17(3): 584 doi: 10.1007/s12072-022-10469-7
|
| 62 |
Kushala W. M. Abeysekera, James G. Orr, Fiona H. Gordon, Laura D. Howe, Julian Hamilton-Shield, Jon Heron, Matthew Hickman. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02401-y
|
| 63 |
Deepika Dhawan, Sheel Sharma. Abdominal Obesity, Adipokines and Non-communicable Diseases. The Journal of Steroid Biochemistry and Molecular Biology 2020; 203: 105737 doi: 10.1016/j.jsbmb.2020.105737
|
| 64 |
Mark L. Dreher. Dietary Patterns and Whole Plant Foods in Aging and Disease. 2018; : 3 doi: 10.1007/978-3-319-59180-3_1
|
| 65 |
Moushira Zaki, Darine Amin, Ramy Mohamed. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease. Journal of Complementary and Integrative Medicine 2021; 18(2): 385 doi: 10.1515/jcim-2020-0073
|
| 66 |
Hongbin Li, Meihao Guo, Zhen An, Jun Meng, Jing Jiang, Jie Song, Weidong Wu. Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China. International Journal of Environmental Research and Public Health 2020; 17(6): 1818 doi: 10.3390/ijerph17061818
|
| 67 |
Chieh-Chen Wu, Wen-Chun Yeh, Wen-Ding Hsu, Md. Mohaimenul Islam, Phung Anh (Alex) Nguyen, Tahmina Nasrin Poly, Yao-Chin Wang, Hsuan-Chia Yang, Yu-Chuan (Jack) Li. Prediction of fatty liver disease using machine learning algorithms. Computer Methods and Programs in Biomedicine 2019; 170: 23 doi: 10.1016/j.cmpb.2018.12.032
|
| 68 |
Cheng-Wei Lu, Ming-Shyan Lin, Yu-Sheng Lin, I-Jen Chang, Ming-Horng Tsai, Kuo-Liang Wei, Mei-Yen Chen. Aminotransferase Ratio Is a Useful Index for Hepatosteatosis in Children and Adolescents. Gastroenterology Nursing 2019; 42(6): 486 doi: 10.1097/SGA.0000000000000389
|
| 69 |
Lijie Kong, Chaojie Ye, Yiying Wang, Chun Dou, Jie Zheng, Shuangyuan Wang, Hong Lin, Zhiyun Zhao, Mian Li, Yu Xu, Yuhong Chen, Jieli Lu, Min Xu, Weiqing Wang, Guang Ning, Yufang Bi, Tiange Wang. Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study. Journal of Diabetes 2024; 16(1) doi: 10.1111/1753-0407.13459
|
| 70 |
Seo Young Kang, Ye-Jee Kim, Hye Soon Park. Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998–2035. Journal of Clinical Medicine 2020; 9(8): 2626 doi: 10.3390/jcm9082626
|
| 71 |
Keke Lu, Jing Wang, Yueyuan Yu, Yikuan Wu, Zhao He. Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice. Food Science & Nutrition 2020; 8(6): 2588 doi: 10.1002/fsn3.1445
|
| 72 |
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism 2019; 92: 82 doi: 10.1016/j.metabol.2018.11.014
|
| 73 |
Imran M. Paruk, Fraser J. Pirie, Ayesha A. Motala. Non-alcoholic fatty liver disease in Africa: a hidden danger. Global Health, Epidemiology and Genomics 2019; 4 doi: 10.1017/gheg.2019.2
|
| 74 |
Dani O. Gonzalez, Marc P. Michalsky. Update on pediatric metabolic and bariatric surgery. Pediatric Obesity 2021; 16(8) doi: 10.1111/ijpo.12794
|
| 75 |
Ying-Ying CHEN, Yan YAN, Zheng ZHAO, Mei-Jing SHI, Yu-Bin ZHANG. Bofutsushosan ameliorates obesity in mice through modulating PGC-1α expression in brown adipose tissues and inhibiting inflammation in white adipose tissues. Chinese Journal of Natural Medicines 2016; 14(6): 449 doi: 10.1016/S1875-5364(16)30042-5
|
| 76 |
Eman Helal, Fatma Elgebaly, Nasser Mousa, Sherif Elbaz, Mostafa Abdelsalam, Eman Abdelkader, Amr El-Sehrawy, Niveen El-wakeel, Ola El-Emam, Manal Hashem, Alaa Elmetwalli, Shimaa Mansour. Diagnostic performance of new BAST score versus FIB-4 index in predicating of the liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-02032-x
|
| 77 |
Vian Ahmed Wasta Esmail, Mohammed Omer Mohammed, Marwan S.M. Al-Nimer. Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome. Arab Journal of Gastroenterology 2021; 22(1): 1 doi: 10.1016/j.ajg.2020.12.005
|
| 78 |
Danny Con, Steven Tu, Daniel Clayton-Chubb, John S. Lubel, Amanda J. Nicoll, Rohit Sawhney, Stephen Bloom. Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B. Digestive Diseases and Sciences 2024; 69(4): 1496 doi: 10.1007/s10620-024-08354-4
|
| 79 |
Hisayuki Katsuyama, Seiichi Horinaka, Mariko Hakoshima, Hiroki Adachi, Hidekatsu Yanai. Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients. Journal of Clinical Medicine 2024; 13(16): 4929 doi: 10.3390/jcm13164929
|
| 80 |
Samira Soltanieh, Marieh Salavatizadeh, Hossein Poustchi, Zahra Yari, Asieh Mansour, Mohammad E. Khamseh, Mojtaba Malek, Fariba Alaei-Shahmiri, Azita Hekmatdoost. The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM). Heliyon 2023; 9(3): e13983 doi: 10.1016/j.heliyon.2023.e13983
|
| 81 |
Jiahua Fan, Shiyun Luo, Yongxin Ye, Jingmeng Ju, Zhuoyu Zhang, Ludi Liu, Jialu Yang, Min Xia. Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population. Nutrition & Metabolism 2021; 18(1) doi: 10.1186/s12986-021-00611-x
|
| 82 |
Ki-Jin Ryu, Hyuntae Park, Yong Jin Kim, Kyong Wook Yi, Jung Ho Shin, Jun Young Hur, Tak Kim. Moderate to severe vasomotor symptoms are risk factors for non-alcoholic fatty liver disease in postmenopausal women. Maturitas 2018; 117: 22 doi: 10.1016/j.maturitas.2018.08.011
|
| 83 |
Changhui Yu, Shiming He, Maobin Kuang, Chao Wang, Xin Huang, Guotai Sheng, Yang Zou. Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study. BMC Endocrine Disorders 2024; 24(1) doi: 10.1186/s12902-024-01554-z
|
| 84 |
Maria De Luca, Denise Vecchie’, Baskaran Athmanathan, Sreejit Gopalkrishna, Jennifer A. Valcin, Telisha M. Swain, Rogerio Sertie, Kennedy Wekesa, Glenn C. Rowe, Shannon M. Bailey, Prabhakara R. Nagareddy. Genetic Deletion of Syndecan-4 Alters Body Composition, Metabolic Phenotypes, and the Function of Metabolic Tissues in Female Mice Fed A High-Fat Diet. Nutrients 2019; 11(11): 2810 doi: 10.3390/nu11112810
|
| 85 |
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, Arun J. Sanyal. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes, Obesity and Metabolism 2021; 23(5): 1069 doi: 10.1111/dom.14322
|
| 86 |
M.ª Teófila Vicente Herrero, M.ª Victoria Ramírez-Iñiguez de la Torre, Ángel Arturo López González. Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia. Revista Clínica de Medicina de Familia 2022; : 93 doi: 10.55783/150205
|
| 87 |
Nora A. Alfadda, Ghadeer S. Aljuraiban, Hadeel M. Awwad, Mohammad S. Khaleel, Abdulrahman M. Almaghamsi, Suphia M. Sherbeeni, Adel N. Alqutub, Abdullah S. Aldosary, Assim A. Alfadda. Higher carbohydrate intake in relation to non-alcoholic fatty liver disease in patients with type 2 diabetes. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.996004
|
| 88 |
Anastasios Serbis, Stergios A. Polyzos, Stavroula A. Paschou, Ekaterini Siomou, Dimitrios N. Kiortsis. Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?. Endocrine 2024; 85(3): 988 doi: 10.1007/s12020-024-03783-7
|
| 89 |
Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. Diabetes, Metabolic Syndrome and Obesity 2023; : 3303 doi: 10.2147/DMSO.S431251
|
| 90 |
Giulia de Alteriis, Gabriella Pugliese, Antonella Di Sarno, Giovanna Muscogiuri, Luigi Barrea, Valentina Cossiga, Giuseppe Perruolo, Michele Francesco Di Tolla, Francesca Zumbolo, Pietro Formisano, Filomena Morisco, Silvia Savastano. Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage. International Journal of Molecular Sciences 2023; 24(13): 10885 doi: 10.3390/ijms241310885
|
| 91 |
Lihe Liu, Jiaxi Lin, Lu Liu, Jingwen Gao, Guoting Xu, Minyue Yin, Xiaolin Liu, Airong Wu, Jinzhou Zhu. Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017–2020. DIGITAL HEALTH 2024; 10 doi: 10.1177/20552076241272535
|
| 92 |
Andreas G. Wibmer, Tobias Becher, Mahmoud Eljalby, Audrey Crane, Pamela Causa Andrieu, Caroline S. Jiang, Roger Vaughan, Heiko Schöder, Paul Cohen. Brown adipose tissue is associated with healthier body fat distribution and metabolic benefits independent of regional adiposity. Cell Reports Medicine 2021; 2(7): 100332 doi: 10.1016/j.xcrm.2021.100332
|
| 93 |
Hye Lyn Lee, Su Jung Baik, Wan Je Cho, Da-Hye Son, Yong-Jae Lee. Combined Effect of Body Mass Index and Waist Circumference in Predicting Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2023; 21(9): 497 doi: 10.1089/met.2023.0114
|
| 94 |
Dina Attia, Shereen Abdel Alem, Wafaa El‐Akel, Wael Abdel‐Razek, Mohamed Eslam, Yasser Fouad, Imam Waked. Prevalence and clinical characteristics of patients with metabolic dysfunction‐associated fatty liver disease with hepatitis C virus infection—a population‐based study. Alimentary Pharmacology & Therapeutics 2022; 56(11-12): 1581 doi: 10.1111/apt.17233
|
| 95 |
Daniel J. McDonough, Mahesh Mathew, Zachary C. Pope, Pamela J. Schreiner, David R. Jacobs, Lisa B. VanWagner, John Jeffrey Carr, James G. Terry, Kelley Pettee Gabriel, Jared P. Reis, Mark A. Pereira. Aerobic and Muscle-Strengthening Physical Activity, Television Viewing, and Nonalcoholic Fatty Liver Disease: The CARDIA Study. Journal of Clinical Medicine 2023; 12(17): 5603 doi: 10.3390/jcm12175603
|
| 96 |
Athina I. Amanatidou, Andriana C. Kaliora, Charalampia Amerikanou, Stefan Stojanoski, Natasa Milosevic, Chara Vezou, Mirjana Beribaka, Rajarshi Banerjee, Ioanna-Panagiota Kalafati, Ilias Smyrnioudis, Mary Jo Kurth, Aimo Kannt, M. Pilar Francino, Sophie Visvikis-Siest, Panos Deloukas, Carlos Llorens, Fernando Marascio, Natasa Milic, Milica Medic-Stojanoska, Amalia Gastaldelli, Maria Giovanna Trivella, George V. Dedoussis. Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study. International Journal of Environmental Research and Public Health 2022; 19(2): 971 doi: 10.3390/ijerph19020971
|
| 97 |
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; : 111 doi: 10.1016/B978-0-12-812504-5.00006-4
|
| 98 |
Laurence J. Dobbie, Claudia Coelho, James Crane, Barbara McGowan. Clinical evaluation of patients living with obesity. Internal and Emergency Medicine 2023; 18(5): 1273 doi: 10.1007/s11739-023-03263-2
|
| 99 |
Azam Doustmohammadian, Bahareh Amirkalali, Esmaeel Gholizadeh, Mahmoodreza Khoonsari, Amir Hossein Faraji, Mehdi Nikkhah, Mansooreh Maadi, Nima Motamed, Mohsen Reza Mansourian, Melika Hajjar, Cain C. T. Clark, Samira Chaibakhsh, Fahimeh Safarnezhad Tameshkel, Arian Afzali, Farhad Zamani. Mediators of dietary diversity score (DDS) on NAFLD in Iranian adults: a structural equation modeling study. European Journal of Clinical Nutrition 2023; 77(3): 370 doi: 10.1038/s41430-022-01240-0
|
| 100 |
George A Bray, William E Heisel, Ashkan Afshin, Michael D Jensen, William H Dietz, Michael Long, Robert F Kushner, Stephen R Daniels, Thomas A Wadden, Adam G Tsai, Frank B Hu, John M Jakicic, Donna H Ryan, Bruce M Wolfe, Thomas H Inge. The Science of Obesity Management: An Endocrine Society Scientific Statement. Endocrine Reviews 2018; 39(2): 79 doi: 10.1210/er.2017-00253
|
| 101 |
Maria Gabriella Caruso, Nicola Veronese, Maria Notarnicola, Anna Maria Cisternino, Rosa Reddavide, Rosa Inguaggiato, Vito Guerra, Rossella Donghia, Antonio Logroscino, Ornella Rotolo, Marisa Chiloiro, Gioacchino Leandro, Giampiero De Leonardis, Valeria Tutino, G Misciagna, Caterina Bonfiglio, Rocco Guerra, Alberto Osella. Fatty liver and mortality: a cohort population study in South Italy. BMJ Open 2019; 9(6): e027379 doi: 10.1136/bmjopen-2018-027379
|
| 102 |
C Wendy Spearman, Mary Afihene, Omolade Betiku, Bilal Bobat, Lina Cunha, Chris Kassianides, Leolin Katsidzira, Hailemichael D Mekonnen, Ponsiano Ocama, Olusegun Ojo, Imran Paruk, Christian Tzeuton, Mark W Sonderup. Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 2021; 6(12): 1036 doi: 10.1016/S2468-1253(21)00275-2
|
| 103 |
Agostino Di Ciaula, Leonilde Bonfrate, Marcin Krawczyk, Gema Frühbeck, Piero Portincasa. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis. International Journal of Molecular Sciences 2022; 23(5): 2636 doi: 10.3390/ijms23052636
|
| 104 |
Sofía Montemayor, Cristina Bouzas, Catalina M. Mascaró, Miguel Casares, Isabel Llompart, Itziar Abete, Escarlata Angullo-Martinez, María Ángeles Zulet, J. Alfredo Martínez, Josep A. Tur. Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study. Nutrients 2022; 14(11): 2223 doi: 10.3390/nu14112223
|
| 105 |
Danting Li, Shengli Wu, Meiyu Zhang, Chengyao Xie, Huiwen Tan, Nong Li. Correlation between triglyceride-glucose index and related parameters and nonalcoholic fatty liver disease in northwest China. International Journal of Diabetes in Developing Countries 2024; 44(3): 496 doi: 10.1007/s13410-023-01255-8
|
| 106 |
Hwi Jin Im, Yo Chan Ahn, Jing-Hua Wang, Myung Min Lee, Chang Gue Son. Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101526 doi: 10.1016/j.clinre.2020.06.022
|
| 107 |
Xiaojuan Peng, Juan Li, Hailiang Zhao, Junlong Lai, Junqin Lin, Shaohui Tang. Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01015-5
|
| 108 |
Saleem Ansari, Hasan Haboubi, Nadim Haboubi. Adult obesity complications: challenges and clinical impact. Therapeutic Advances in Endocrinology and Metabolism 2020; 11 doi: 10.1177/2042018820934955
|
| 109 |
Maya Balakrishnan, Jürgen Rehm. A public health perspective on mitigating the global burden of chronic liver disease. Hepatology 2024; 79(2): 451 doi: 10.1097/HEP.0000000000000679
|
| 110 |
Monica A. Konerman, Patrick Walden, Megan Joseph, Elizabeth A. Jackson, Anna S. Lok, Melvyn Rubenfire. Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2019; 49(3): 296 doi: 10.1111/apt.15063
|
| 111 |
Davide Gnocchi, Carlo Custodero, Carlo Sabbà, Antonio Mazzocca. Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology. Journal of Molecular Medicine 2019; 97(6): 741 doi: 10.1007/s00109-019-01780-2
|
| 112 |
Mariana V. Machado, Sara Policarpo, J Coutinho, Sofia Carvalhana, Jorge Leitão, Armando Carvalho, Ana P. Silva, Francisco Velasco, Isabel Medeiros, Ana Catarina Alves, Mafalda Bourbon, Helena Cortez-Pinto. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?. Obesity Surgery 2020; 30(2): 560 doi: 10.1007/s11695-019-04213-8
|
| 113 |
Peter Manu, Cristina-Mihaela Lăcătuşu, Liliana M. Rogozea, Simona Cernea. Pharmacological Management of Obesity: A Century of Expert Opinions in Cecil Textbook of Medicine. American Journal of Therapeutics 2022; 29(4): e410 doi: 10.1097/MJT.0000000000001524
|
| 114 |
Shari S. Bassuk, JoAnn E. Manson. International Encyclopedia of Public Health. 2017; : 277 doi: 10.1016/B978-0-12-803678-5.00308-8
|
| 115 |
Yedidya Saiman, Royce Hooks, Rotonya M. Carr. High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and Progression. Current Hepatology Reports 2020; 19(4): 412 doi: 10.1007/s11901-020-00539-5
|
| 116 |
Haozhe Cui, Fei Tian, Yongliang Chen, Xiangming Ma. Association between Metabolically Healthy Status and Risk of Gastrointestinal Cancer. Cancer Research and Treatment 2024; 56(1): 238 doi: 10.4143/crt.2023.539
|
| 117 |
Taha Aghajanzadeh, Mahmood Talkhabi, Mohammad Reza Zali, Behzad Hatami, Kaveh Baghaei. Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis. Non-coding RNA Research 2023; 8(4): 471 doi: 10.1016/j.ncrna.2023.06.004
|
| 118 |
Laura Pimpin, Helena Cortez-Pinto, Francesco Negro, Emily Corbould, Jeffrey V. Lazarus, Laura Webber, Nick Sheron. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. Journal of Hepatology 2018; 69(3): 718 doi: 10.1016/j.jhep.2018.05.011
|
| 119 |
Ju Ri Ham, Ra-Yeong Choi, Yongjin Lee, Mi-Kyung Lee. Effects of Edible Insect Tenebrio molitor Larva Fermentation Extract as a Substitute Protein on Hepatosteatogenesis and Proteomic Changes in Obese Mice Induced by High-Fat Diet. International Journal of Molecular Sciences 2021; 22(7): 3615 doi: 10.3390/ijms22073615
|
| 120 |
Yu Zhu, Hu Yang, Shaoxian Liang, Honghua Zhang, Yufeng Mo, Songxian Rao, Yaozong Zhang, Zhuang Zhang, Weiqiang Wang, Wanshui Yang. Higher Adherence to Healthy Lifestyle Score Is Associated with Lower Odds of Non-Alcoholic Fatty Liver Disease. Nutrients 2022; 14(21): 4462 doi: 10.3390/nu14214462
|
| 121 |
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
|
| 122 |
Ningjian Wang, Qin Li, Bing Han, Yi Chen, Chunfang Zhu, Yingchao Chen, Fangzhen Xia, Meng Lu, Ying Meng, Yuyu Guo, Lin Ye, Chunhua Sui, Lin Kuang, Dongping Lin, Yingli Lu. Follicle‐stimulating hormone is associated with non‐alcoholic fatty liver disease in Chinese women over 55 years old. Journal of Gastroenterology and Hepatology 2016; 31(6): 1196 doi: 10.1111/jgh.13271
|
| 123 |
Eun Jeong Kim, Hyun Jin Kim. Nonalcoholic fatty liver disease in obese and nonobese pediatric patients. Korean Journal of Pediatrics 2019; 62(1): 30 doi: 10.3345/kjp.2018.06786
|
| 124 |
Zobair M. Younossi, Kathleen E. Corey, Naim Alkhouri, Mazen Noureddin, Ira Jacobson, Brian Lam, Stephen Clement, Rita Basu, Stuart C. Gordon, Natarajan Ravendhra, Puneet Puri, Mary Rinella, Peter Scudera, Ashwani K. Singal, Linda Henry. Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices. Alimentary Pharmacology & Therapeutics 2020; 52(3): 513 doi: 10.1111/apt.15830
|
| 125 |
Thaharullah Shah Mehreen, Ranjani Harish, Rajan Kamalesh, Ranjit Mohan Anjana, Viswanathan Mohan. Non-alcoholic Fatty Liver Disease in Asian Indian Adolescents and Young Adults. Journal of Diabetology 2021; 12(2): 218 doi: 10.4103/jod.jod_104_20
|
| 126 |
Nurshad Ali, Abu Hasan Sumon, Khandaker Atkia Fariha, Md Asaduzzaman, Rahanuma Raihanu Kathak, Noyan Hossain Molla, Ananya Dutta Mou, Zitu Barman, Mahmudul Hasan, Rakib Miah, Farjana Islam. Assessment of the relationship of serum liver enzymes activity with general and abdominal obesity in an urban Bangladeshi population. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86216-z
|
| 127 |
Haiying Wang, Qiang Wang, Cuimei Liang, Mingxing Su, Xin Wang, Hua Li, Hui Hu, Hongjuan Fang. Acupuncture Regulating Gut Microbiota in Abdominal Obese Rats Induced by High-Fat Diet. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4958294
|
| 128 |
Hye Won Lee, Kwang Joon Kim, Kyu Sik Jung, Young Eun Chon, Ji Hye Huh, Kyeong Hye Park, Jae Bock Chung, Chang Oh Kim, Kwang-Hyub Han, Jun Yong Park, Han-Chieh Lin. The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter. PLOS ONE 2017; 12(10): e0187066 doi: 10.1371/journal.pone.0187066
|
| 129 |
Gardar Sveinbjornsson, Magnus O. Ulfarsson, Rosa B. Thorolfsdottir, Benedikt A. Jonsson, Eythor Einarsson, Gylfi Gunnlaugsson, Solvi Rognvaldsson, David O. Arnar, Magnus Baldvinsson, Ragnar G. Bjarnason, Thjodbjorg Eiriksdottir, Christian Erikstrup, Egil Ferkingstad, Gisli H. Halldorsson, Hannes Helgason, Anna Helgadottir, Lotte Hindhede, Grimur Hjorleifsson, David Jones, Kirk U. Knowlton, Sigrun H. Lund, Pall Melsted, Kristjan Norland, Isleifur Olafsson, Sigurdur Olafsson, Gudjon R. Oskarsson, Sisse Rye Ostrowski, Ole Birger Pedersen, Auðunn S. Snaebjarnarson, Emil Sigurdsson, Valgerdur Steinthorsdottir, Michael Schwinn, Gudmundur Thorgeirsson, Gudmar Thorleifsson, Ingileif Jonsdottir, Henning Bundgaard, Lincoln Nadauld, Einar S. Bjornsson, Ingrid C. Rulifson, Thorunn Rafnar, Gudmundur L. Norddahl, Unnur Thorsteinsdottir, Patrick Sulem, Daniel F. Gudbjartsson, Hilma Holm, Kari Stefansson. Multiomics study of nonalcoholic fatty liver disease. Nature Genetics 2022; 54(11): 1652 doi: 10.1038/s41588-022-01199-5
|
| 130 |
Eunice S Thomson, Akash T Oommen, Sheejamol V S, Gopalakrishna Pillai. Comparison of Non-invasive Liver Fat Scoring Systems as Markers of Metabolic Dysfunction-Associated Liver Disease. Cureus 2024; doi: 10.7759/cureus.72222
|
| 131 |
Cecilia C. Garcia, Bárbara Piotrkowski, Plácida Baz, Daniel Poncino, Javier Benavides, Luis Colombato, María Laura Reyes Toso, Silvina Yantorno, Valeria Descalzi, Gabriel E. Gondolesi, Cesar G. Fraga, Alejandra C. Cherñavsky. A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2022; 67(7): 3006 doi: 10.1007/s10620-021-07105-z
|
| 132 |
Le Zhang, Mortada El-Shabrawi, Louise A. Baur, Christopher D. Byrne, Giovanni Targher, Mohit Kehar, Gilda Porta, Way Seah Lee, Sander Lefere, Serap Turan, Anna Alisi, Ram Weiss, Maria Felicia Faienza, Ambika Ashraf, Shikha S. Sundaram, Anshu Srivastava, Ruth De Bruyne, Yunkoo Kang, Flora Bacopoulou, Yong-Hai Zhou, Andy Darma, Monica Lupsor-Platon, Masahide Hamaguchi, Anoop Misra, Nahum Méndez-Sánchez, Nicholas Beng Hui Ng, Claude Marcus, Amanda E. Staiano, Nadia Waheed, Saleh A. Alqahtani, Cosimo Giannini, Ponsiano Ocama, Mindie H. Nguyen, Maria Teresa Arias-Loste, Mohamed Rabea Ahmed, Giada Sebastiani, Yong Poovorawan, Mamun Al Mahtab, Juan M. Pericàs, Themis Reverbel da Silveira, Peter Hegyi, Amer Azaz, Hasan M. Isa, Chatmanee Lertudomphonwanit, Mona Issa Farrag, Ahmed Abd Alwahab Nugud, Hong-Wei Du, Ke-Min Qi, Nezha Mouane, Xin-Ran Cheng, Tawfiq Al Lawati, Eleonora D.T. Fagundes, Hasmik Ghazinyan, Adamos Hadjipanayis, Jian-Gao Fan, Nicoleta Gimiga, Naglaa M. Kamal, Gabriela Ștefănescu, Li Hong, Smaranda Diaconescu, Ming Li, Jacob George, Ming-Hua Zheng. An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease. Med 2024; 5(7): 797 doi: 10.1016/j.medj.2024.03.017
|